1
/
of
1
Elabscience
SKU:E-CL-H0663
Human SNCα(Synuclein Alpha) CLIA Kit
Human SNCα(Synuclein Alpha) CLIA Kit
Regular price
$682.00 USD
Regular price
Sale price
$682.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the HUMAN SNCΑ (Synuclein Alpha) CLIA Kit, a cutting-edge solution designed to facilitate accurate and efficient measurement of Synuclein Alpha levels in human samples. This state-of-the-art kit is meticulously crafted to meet the highest standards of quality and reliability, ensuring precise and reproducible results.
The HUMAN SNCΑ CLIA Kit employs a highly sensitive Chemiluminescent Immunoassay (CLIA) technique, enabling the detection and quantification of Synuclein Alpha with exceptional sensitivity and specificity. This advanced methodology guarantees optimal performance, allowing for the precise determination of Synuclein Alpha concentrations in various biological matrices.
With its user-friendly design, the HUMAN SNCΑ CLIA Kit offers a streamlined workflow, minimizing the complexity and time required for sample analysis. The kit includes all necessary components, meticulously optimized to ensure optimal assay performance, including pre-coated microplates, assay buffers, and a comprehensive set of standards and controls.
Furthermore, the HUMAN SNCΑ CLIA Kit boasts a wide dynamic range, enabling the accurate measurement of Synuclein Alpha concentrations across a broad spectrum. This versatility makes it an invaluable tool for a diverse range of research applications, including neurodegenerative disease studies, biomarker discovery, and therapeutic development.
Rest assured, the HUMAN SNCΑ CLIA Kit is manufactured in strict accordance with rigorous quality control standards, guaranteeing the utmost reliability and reproducibility of results. Each kit undergoes meticulous testing to ensure batch-to-batch consistency, providing researchers with the confidence to obtain accurate and reliable data.
In summary, the HUMAN SNCΑ CLIA Kit represents a breakthrough in Synuclein Alpha analysis, offering researchers a powerful and reliable tool to advance their scientific endeavors. With its exceptional sensitivity, user-friendly design, and stringent quality control, this kit is poised to revolutionize the field of neurodegenerative disease research.
The HUMAN SNCΑ CLIA Kit employs a highly sensitive Chemiluminescent Immunoassay (CLIA) technique, enabling the detection and quantification of Synuclein Alpha with exceptional sensitivity and specificity. This advanced methodology guarantees optimal performance, allowing for the precise determination of Synuclein Alpha concentrations in various biological matrices.
With its user-friendly design, the HUMAN SNCΑ CLIA Kit offers a streamlined workflow, minimizing the complexity and time required for sample analysis. The kit includes all necessary components, meticulously optimized to ensure optimal assay performance, including pre-coated microplates, assay buffers, and a comprehensive set of standards and controls.
Furthermore, the HUMAN SNCΑ CLIA Kit boasts a wide dynamic range, enabling the accurate measurement of Synuclein Alpha concentrations across a broad spectrum. This versatility makes it an invaluable tool for a diverse range of research applications, including neurodegenerative disease studies, biomarker discovery, and therapeutic development.
Rest assured, the HUMAN SNCΑ CLIA Kit is manufactured in strict accordance with rigorous quality control standards, guaranteeing the utmost reliability and reproducibility of results. Each kit undergoes meticulous testing to ensure batch-to-batch consistency, providing researchers with the confidence to obtain accurate and reliable data.
In summary, the HUMAN SNCΑ CLIA Kit represents a breakthrough in Synuclein Alpha analysis, offering researchers a powerful and reliable tool to advance their scientific endeavors. With its exceptional sensitivity, user-friendly design, and stringent quality control, this kit is poised to revolutionize the field of neurodegenerative disease research.
Share
